Lin S J, Hong C Y, Chiang B N, Wei Y H
Clin Exp Hypertens A. 1985;7(8):1151-63. doi: 10.3109/10641968509073581.
The Na+, K+-ATPase activity in the erythrocyte membrane was measured in 25 untreated essential hypertensive patients and 25 age-matched healthy normotensive subjects. In addition, the Ca2+, Mg2+-ATPase activity was measured in 20 hypertensive and 25 age-matched normotensive subjects. The Na+, K+-ATPase activity of healthy Chinese measured in this study was similar to the data reported in a Dutch study. We therefore could not support a theory which speculated an ethnic influence on Na+, K+-ATPase activity. Both Na+, K+-ATPase and Ca2+, Mg2+-ATPase activities were slightly lower in hypertensive patients as compared with those in normotensive subjects, but the differences were not statistically significant. We concluded that the transport ATPase activities were not impaired in the erythrocyte membranes of hypertensive patients.
在25例未经治疗的原发性高血压患者和25例年龄匹配的健康血压正常受试者中测量了红细胞膜中的钠钾ATP酶活性。此外,在20例高血压患者和25例年龄匹配的血压正常受试者中测量了钙镁ATP酶活性。本研究中测量的健康中国人的钠钾ATP酶活性与荷兰一项研究报告的数据相似。因此,我们无法支持一种推测种族对钠钾ATP酶活性有影响的理论。与血压正常受试者相比,高血压患者的钠钾ATP酶和钙镁ATP酶活性均略低,但差异无统计学意义。我们得出结论,高血压患者红细胞膜中的转运ATP酶活性未受损。